1. Introduction {#sec1}
===============

Posttraumatic stress disorder (PTSD) develops following a stressful event or situation of an exceptionally threatening or catastrophic nature, which is likely to cause pervasive distress \[[@B1]\]. PTSD is classified as an anxiety disorder and is typically defined by the coexistence of 3 clusters of symptoms, namely, *reexperiencing*, *marked avoidance*, and *hyperarousal*\[[@B2]\]. The prevalence rates of PTSD have been reported as 6--25% \[[@B3]\], and approximately 25--30% of people experiencing a traumatic event may go on to develop PTSD \[[@B4]\].

Current first-line PTSD therapies include trauma-focused cognitive behavioral therapy (CBT), stress inoculation training, and pharmacotherapies \[[@B5]\]. Complementary and alternative medicine (CAM) interventions include a range of therapies that are not considered standard to the practice of medicine in the USA. CAM therapies are widely used by mental health consumers, including veterans, and numerous stakeholders have expressed strong interest in fostering the evidence base for these approaches in PTSD \[[@B6]\]. In addition, approximately 21% of CAM users met diagnostic criteria for at least one problematic mental disorder, according to one study \[[@B7]\].

Acupuncture is commonly recognized worldwide as a mainstream CAM therapy. Acupuncture is the practice of inserting a needle or needles into certain points in the body, known as meridian acupuncture points, for therapeutic or preventive purposes \[[@B8]\]. Numerous studies have shown that acupuncture is well tolerated by patients, safe, and cost effective compared to routine care \[[@B9]\].

Additionally, acupuncture is widely used in mental disorders such as anxiety disorders \[[@B10]\], dementia \[[@B11]\], eating disorders \[[@B12]\], schizophrenia \[[@B13]\], sleep disorders \[[@B14]\], and substance-related disorders \[[@B15], [@B16]\]. Electroacupuncture is effective in rat models of stress and thus might be a useful adjunct therapy in stress-related anxiety disorders \[[@B17]\]. Acupuncture has positive effects in PTSD patients, although the evidence is still lacking as to its true efficacy for this condition \[[@B18]\].

There have been two reviews published on acupuncture or its variants for PTSD \[[@B19], [@B20]\]. David Feinstein reviewed 2 randomized controlled trials (RCTs) and 6 outcome studies which tested whether brief psychological exposure with acupoint tapping was effective for PTSD or not and its conclusion was not confirmative \[[@B19]\]. Also Michael Hollifield reviewed acupuncture for PTSD referring one published and one unpublished clinical trial and suggested further definitive research is needed because of lack of well-conducted RCTs \[[@B20]\]. However, there has been no systematic review published to date fully summarizing the current total evidence about the quality and effectiveness of acupuncture for PTSD. For this reason, we conducted a systematic review of RCTs and prospective clinical trials to assess critically whether acupuncture improves the symptoms of PTSD and to make recommendations for future research based on gap areas identified in this review.

2. Methods {#sec2}
==========

2.1. Data Sources and Search Strategy {#sec2.1}
-------------------------------------

Following the COSI model \[[@B21]\], we searched the following electronic databases over time periods from their inception to July 2012: Cochrane Database of Systematic Reviews, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE through PubMed, EMBASE, Allied and Complementary Medicine Database (AMED), CINAHL, Pilots, Google, Korean databases (which include DBpia, Korea Institute of Science and Technology Information (KISTI), KoreaMed, Korean traditional knowledge portal, OASIS, RISS, the National Assembly Library, and The National Library of Korea), Chinese databases (which include China Academic Journal, <http://www.cqvip.com> and WANFANG DATA), and a Japanese database (Japan Science and Technology Information Aggregator Electronic). We also searched the grey literature; unpublished trials were searched via the Register of the Controlled Trials databases ( <http://www.controlled-trials.com> and <http://www.clinicaltrials.gov>), and we communicated with identified experts in the field of acupuncture and PTSD, searched our departmental files, and pearled the references of all included articles for other relevant articles perhaps not picked up through other methods of searching.

The key search terms were "(acupuncture OR acup\*) AND (stress disorders, post-Traumatic OR posttraumatic stress disorder OR posttraumatic stress disorder OR PTSD)." MeSH strategy was applied to ensure the most powerful search where applicable. Search strategies were adjusted for each of the databases. Personal contacts were made with the original authors of the searched studies to identify any potential missing data from the publications.

2.2. Study Selection {#sec2.2}
--------------------

Two psychiatrists (J. H. Lim and H. W. Kang) actively participated in the study selection process based on clinical expertise, and two experienced researchers (B. C. Shin, C. Cindy) monitored the whole process of systematic review. All reviewers were fully trained in the systematic review process executed.

### 2.2.1. Types of Studies {#sec2.2.1}

The review was not restricted by study design, however, study should be prospective clinical trials. We included RCTs and nonrandomized controlled trials that compared acupuncture or its variants with a control or control groups. We also included uncontrolled clinical trials (UCTs) of acupuncture for PTSD to give our research question a more solid ground or to make recommendations for future research. However, we separately analyzed RCTs and others, and interpreted more weighted on RCTs because of research quality following the validity of evidence. No restrictions were imposed on studies with regard to blinding, languages, or year published.

### 2.2.2. Types of Participants {#sec2.2.2}

We selected all studies including patients with PTSD diagnosed by any set of criteria, DSM-IV or ICD-10, regardless of gender, age, nationality, or outpatient therapy or inpatient therapy.

### 2.2.3. Types of Interventions/Controls {#sec2.2.3}

Clinical trials investigating any type of needling acupuncture, specifically classical acupuncture, electroacupuncture, auricular acupuncture were included. We also included trials that included acupuncture as a more complex intervention, that is, acupuncture plus another intervention if the comparison group was that other intervention. We included trials using control groups with no treatment, sham/placebo acupuncture, and conventional treatments for PTSD patients. We excluded laser acupuncture and acupoint stimulation such as acupressure, moxibustion, tapping, and so forth because of the lack of needling. We excluded trials with controls that acted as "healthy participants."

### 2.2.4. Types of Outcome Measures {#sec2.2.4}

The most recent guideline for treatment of PTSD \[[@B5]\] includes the following major outcomes: 1st: "reduction in severity of PTSD symptoms"; 2nd: "prevention/reduction of trauma-related comorbid conditions"; 3rd: "patient adherence to treatment plan"; 4th:"response to treatment"; 5th: "social, occupational, adaptive, and interpersonal functioning"; 6th: "quality of life" and 7th: "rate of relapse." The main outcome measures were any relevant PTSD scales as clinician-administered PTSD scale (CAPS), depression scale, and anxiety scale. Other scales as related to impairment, proportion of patients recovered were extracted following predefined protocol.

2.3. Screening, Data Extraction, and Quality Assessment {#sec2.3}
-------------------------------------------------------

After screening titles and abstracts retrieved through our search, we excluded all articles that did not match our inclusion/exclusion criteria according to the predefined eligibility criteria mentioned above. Then, expected inclusions were carefully read in full text, and final inclusion was decided by two independent reviewers (Y. D. Kim, I. Heo) by matching method. If studies were written in languages incomprehensible for the reviewers, all articles not written in native language were translated by colleagues. Then we first classified these by the eligibility criteria. If there was a need for full text review, we evaluated these after translation. Data were extracted independently based on predefined characteristics to describe each study (refer to [Table 1](#tab1){ref-type="table"}) by the two reviewers. All disagreements were resolved by discussion and consensus, or by the first author. The Cochrane risk of bias for assessing the quality of included RCTs \[[@B22]\], the CONSORT 2010 checklist for reporting quality of RCTs \[[@B23]\] and the revised standards for reporting interventions in clinical trials of acupuncture (STRICTA) guideline for reporting quality of acupuncture trials \[[@B24]\] were used to evaluate the methodological quality of the included publications. All reviewers were fully trained in the quality assessment and data extraction methodology.

2.4. Data Synthesis and Statistics {#sec2.4}
----------------------------------

Two authors (Y. D. Kim, B. C. Shin) calculated effect estimates (effect size: ES) to summarize the effects of acupuncture on each outcome by recalculation for mean and standard deviation (SD) because all original data were continuous ones. The standardized mean difference (SMD) and 95% confidence interval (CI) on each outcome measurement were calculated using Cochrane Collaboration software (Review Manager (RevMan) Version 5.1.7 for Windows. Copenhagen: The Nordic Cochrane Centre). For meta-analysis, we pooled data across studies using weighted mean difference (WMD) because same measurement was used. Random effect model was used because clinical heterogeneities were expected across the studies. To assess the heterogeneity among the trials, Chi-square test and the Higgins *I* ^2^ test were used.

3. Results {#sec3}
==========

3.1. Study Description {#sec3.1}
----------------------

The searches retrieved 136 potentially relevant articles. After screening the titles and abstracts, we excluded 120 studies ([Figure 1](#fig1){ref-type="fig"}). 16 articles were read in full and evaluated. Subsequently, 5 studies were excluded because 1 was a controlled trial but the control group members were healthy subjects \[[@B25]\], 1 was active status not recruiting \[[@B26]\], 1 was recruiting status \[[@B27]\], and 2 were completed but with the results not published \[[@B28], [@B29]\]. Finally 9 RCTs and 2 UCTs were identified. Of 9 RCTs published, Zhang et al. RCT \[[@B30]\] was split or duplicated published with same data \[[@B30], [@B31]--[@B35]\]. So we included only 1 RCT with full data \[[@B30]\] from the 6 RCTs \[[@B30], [@B31]--[@B35]\]. Consequently, 4 RCTs \[[@B18], [@B30]--[@B37]\] and 2 UCTs \[[@B38], [@B39]\] met our inclusion criteria. [Figure 1](#fig1){ref-type="fig"} sums up the search results based on a four-phase flow diagram in Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement format \[[@B40]\]. The key data are summarized in [Table 1](#tab1){ref-type="table"}. One RCT originated from the USA \[[@B18]\], while all the others were from China \[[@B30]--[@B39]\]. All RCTs adopted a parallel-group design. Two of them were two-parallel-arm group designs \[[@B36], [@B37]\], one was a three-parallel-arm group design \[[@B18]\], and one was a four-parallel-arm group design \[[@B30]\]. Two RCTs \[[@B18], [@B30]\] were based on a sample size calculation, whereas the other two RCTs \[[@B36], [@B37]\] did not report this.

The four RCTs evaluated 543 PTSD patients (mean sample size per arm: 49). The duration of treatment was 1 to 12 weeks. A table showing baseline clinical characteristics for each group was reported in only one RCT \[[@B18]\].

3.2. Interventions {#sec3.2}
------------------

One RCT compared needle acupuncture to cognitive-behavioral therapy (CBT) and a waitlist control \[[@B18]\], and another used electroacupuncture only or with moxibustion or with auricular acupuncture versus oral selective serotonin reuptake inhibitors (SSRIs) \[[@B30]\]. One RCT tested electroacupuncture plus moxibustion versus oral SSRI \[[@B36]\], and one RCT compared acupoint stimulation plus CBT to CBT alone \[[@B37]\]. One UCT \[[@B39]\] used just acupuncture, the other UCT \[[@B38]\] used electroacupuncture plus auricular acupuncture and moxibustion. 1 RCT \[[@B18]\] and 1 UCT \[[@B39]\] used manual stimulation without electrical stimulation, and the other 3 RCTs \[[@B30]--[@B37]\] and 1 UCT \[[@B38]\] used electrical stimulation.

3.3. Outcomes {#sec3.3}
-------------

### 3.3.1. Acupuncture versus CBT/Acupuncture versus Waitlist Control/CBT versus Waitlist Control {#sec3.3.1}

One high-quality RCT evaluated the effect of acupuncture against CBT and a waitlist control \[[@B18]\]. No statistical difference was found between acupuncture and CBT. But, acupuncture treatment was statistically superior to waitlist control on four outcome measures; posttraumatic symptom scale-self report (PSS-SR) (ES, −0.98; *P* = 0.001), Depression: self-rated Hopkins symptom checklist-25 (HSCL-25) (ES, −0.68; *P* = 0.02), Anxiety: HSCL-25 (ES, −0.91; *P* = 0.003), and Impairment: Sheehan Disability Inventory (SDI) (ES, −0.64; *P* = 0.03, [Table 1](#tab1){ref-type="table"}). The CBT was also statistically superior to waitlist control on four outcome measures; PSS-SR (ES, −0.85; *P* = 0.004), Depression: HSCL-25 (ES, −0.80; *P* = 0.008), Anxiety: HSCL-25 (ES, −0.79; *P* = 0.008), Impairment (ES, −0.64; *P* = 0.03). The therapeutic effects of acupuncture and CBT were similar on the ESs \[[@B41]\] ([Table 1](#tab1){ref-type="table"}).

### 3.3.2. Acupuncture versus Oral SSRI {#sec3.3.2}

One RCT evaluated the effect of electroacupuncture versus oral SSRI \[[@B30]\]. No statistical difference was found between two groups.

### 3.3.3. Acupuncture Plus CBT versus CBT Alone {#sec3.3.3}

One RCT assessed the effect of acupoint stimulation plus CBT in comparison to CBT alone \[[@B37]\]. Recalculation of the mean difference (MD) revealed a favorable effect of acupoint stimulation plus CBT in terms of IES-R (ES, −1.56; *P* \< 0.00001) and the self-compiled questionnaire (ES, −0.59; *P* = 0.01) ([Table 1](#tab1){ref-type="table"}).

### 3.3.4. Acupuncture Plus Moxibustion versus Oral SSRI {#sec3.3.4}

Two RCTs assessed the effects of electroacupuncture plus moxibustion against oral SSRI \[[@B30], [@B36]\]. One RCT reported no statistical difference between the two groups \[[@B30]\]. However, the other RCT showed that electroacupuncture plus moxibustion was statistically superior to oral SSRI on outcome clinician-administered PTSD scale (CAPS) (ES, −1.77; *P* \< 0.00001), depression (ES, −1.96; *P* \< 0.00001), and anxiety (ES, −1.53; *P* \< 0.00001) \[[@B36]\] ([Table 1](#tab1){ref-type="table"}).

The meta-analysis of electroacupuncture plus moxibustion versus oral SSRI showed a significant favorable effect of electroacupuncture plus moxibustion on outcome CAPS (2 studies, *n* = 115, ES, −3.19; 95% CI: −3.93 to −2.46, *P* \< 0.00001, heterogeneity: *χ* ^2^ = 0.50, *P* = 0.48, *I* ^2^ = 0%), depression (2 studies, *n* = 115, ES, −1.76; 95% CI: −2.21 to −1.31, *P* \< 0.00001, heterogeneity: *χ* ^2^ = 1.04, *P* = 0.31, *I* ^2^ = 4%), and anxiety (2 studies, *n* = 115, ES, −1.14; 95% CI: −1.44 to −0.84, *P* \< 0.00001, heterogeneity: *χ* ^2^ = 0.62, *P* = 0.43, *I* ^2^ = 0%) ([Table 4](#tab4){ref-type="table"}).

### 3.3.5. Acupuncture Treatment in 2 UCTs {#sec3.3.5}

Two UCTs evaluated acupuncture treatment for total 103 earthquake-caused PTSD patients and showed effectiveness of 94.2% \[[@B38]\] and 91.2% \[[@B39]\], respectively ([Table 1](#tab1){ref-type="table"}).

### 3.3.6. Adverse Events {#sec3.3.6}

Of all 6 studies, 2 RCTs described adverse events related to needle acupuncture \[[@B18], [@B30]\]. One study noted that some patients (original paper did not report the exact number) mentioned roughness of operational practices, fear of needles, bleeding, hematoma, pain, and fainting \[[@B30]\]. Another study reported just one perceived adverse effect (kidney pain) as a reason for withdrawal from acupuncture treatment \[[@B18]\]. No serious adverse events were reported.

3.4. Risk of Bias and Reporting Quality {#sec3.4}
---------------------------------------

### 3.4.1. Risk of Bias in Included RCTs Based on Cochrane Criteria {#sec3.4.1}

The risk of bias was low in one RCT \[[@B18]\], whereas one trial \[[@B30]\] had a moderate risk of bias and two trials \[[@B36], [@B37]\] had a high risk of bias in most categories ([Table 2](#tab2){ref-type="table"}). Two RCTs employed adequate sequence generation methods and allocation concealment \[[@B18], [@B30]\], whereas the other two \[[@B36], [@B37]\] failed to report those categories. Assessor blinding was reported in the former two RCTs \[[@B18], [@B30]\]. The risk of bias for incomplete outcome data was low in only one RCT \[[@B18]\]. In all, the four included RCTs had an unclear risk of bias in terms of selective reporting and other sources of bias.

### 3.4.2. Reporting Quality of 4 Included RCTs Based on CONSORT 2010 Checklist {#sec3.4.2}

Many leading medical journals and major international editorial groups have endorsed the CONSORT statement, and the statement facilitates critical appraisal and interpretation of RCTs \[[@B23]\]. For this reason, the current review assessed the reporting quality of included RCTs based on the CONSORT 2010 guideline. The 4 included RCTs described 22 items (59.5%) \[[@B18]\] among 37 items, 15 items (40.5%) \[[@B30]\], 9 items (24.3%) \[[@B36]\], and 8 items (21.6%) \[[@B37]\] according to the CONSORT 2010 checklist \[[@B23]\].

### 3.4.3. Reporting Quality of 4 Included RCTs Based on Revised STRICTA {#sec3.4.3}

The STRICTA reporting guideline is an extension of CONSORT was designed to improve the completeness and transparency of reporting of interventions in controlled trials of acupuncture \[[@B24]\], so that such trials may be more accurately interpreted and readily replicated \[[@B24]\]. The reporting quality of acupuncture was high for two of the included RCTs \[[@B18], [@B30]\], medium in one \[[@B36]\], and low in remaining RCT \[[@B37]\]. The 4 included RCTs reported 16 of 17 items (94.1%) \[[@B18]\], 15 items (88.2%) \[[@B30]\], 13 items (76.5%) \[[@B36]\], and 8 items (47.1%) \[[@B37]\] according to the revised STRICTA guideline. The two high-quality trials \[[@B18], [@B30]\] presented almost all items transparently except one or two items, whereas the low-quality trial \[[@B37]\] did not describe clearly even the reported 8 items ([Table 3](#tab3){ref-type="table"}).

4. Discussion {#sec4}
=============

This is the first systematic review and meta-analysis of prospective clinical trials on the effectiveness of acupuncture for treatment of PTSD. Only 4 RCTs and 2 UCTs met the inclusion criteria for this review. Our main finding of this review is that acupuncture is effective for PTSD based on one high-quality RCT \[[@B18]\] and a meta-analysis.

The high-quality RCT showed that acupuncture had statistically significant effects compared to a waitlist control, although no statistical difference was found between acupuncture and CBT. Also the therapeutic effect of acupuncture was similar with CBT therapy based on the trial. Additionally, the clinical improvement related to acupuncture or CBT lasted for at least 3 months after the end of treatment in the high-quality RCT.

The meta-analysis showed that acupuncture plus moxibustion was superior to oral SSRI for PTSD. But, we should interpret these results with caution because the meta-analysis was based on one medium-quality RCT \[[@B30]\] and one low-quality RCT \[[@B36]\].

One RCT \[[@B37]\] showed that acupoint stimulation plus CBT was more effective than CBT alone in reducing PTSD symptoms. However, acupuncture treatment was not described transparently. Therefore, this result had doubtful reliability.

We found a similar pattern of reporting quality when comparing the Cochrane risk of bias \[[@B22]\] with the CONSORT 2010 checklist \[[@B23]\]. Two of the included studies \[[@B18], [@B30]\] had a high reporting quality in terms of acupuncture based on the revised STRICTA guideline \[[@B24]\]. All the studies failed to describe in detail adverse effects related to acupuncture.

We would like to emphasize the clinical importance of acupuncture for PTSD. Acupuncture might be useful in emergency medicine \[[@B42]\]. A recent case series study suggested possible effectiveness of acupuncture in emergency conditions involving PTSD and emotional trauma \[[@B43]\]. In addition, acupuncture is a conveniently portable medical device for taking emergency measures, and it is very cheap, safe, and easy to handle for trained practitioners.

According to a study \[[@B44]\], during long-term SSRI therapy, the most troubling adverse effects were sexual dysfunction, weight gain, and sleep disturbance. The incidence rate of sexual dysfunction was reported as 2% to 7% \[[@B45]\]. Mean weight gain of 10.8 kg (24 lbs) was found after 6 to 12 months of paroxetine therapy \[[@B46]\]. On the other hand, for acupuncture, "mild" adverse events of such as bleeding, bruising, pain on needling occurred in rate of 6.8% (2,178 out of 31,822 sessions) \[[@B47]\]. And no serious adverse events were reported in total 66,229 treatment sessions according to two studies \[[@B47], [@B48]\]. Therefore acupuncture may be a relatively safe alternative for PTSD in contrast to SSRI, if long-term therapy is needed for treatment.

This systematic review has several limitations. First, although we made strong efforts to retrieve all RCTs on the subject, the evidence reviewed is potentially incomplete because only one rigorous study was included. Second, because there was no RCT on PTSD with a sham acupuncture control, we could not evaluate the effects of acupuncture compared to an inert placebo control \[[@B49]\]. Third, study design was quite different across the four included RCTs. Two RCTs \[[@B18], [@B30]\] compared acupuncture with different controls (CBT and oral SSRI), and the other two RCTs \[[@B36], [@B37]\] employed acupuncture as a cointervention of moxibustion and CBT. These very different designs across studies prevented us from abstracting a firm conclusion. Furthermore, the paucity of included trials and the suboptimal methodological quality of the primary data overall, except for one high-quality trial, are also important vulnerabilities of this review.

In total, from these drawbacks we could suggest several important recommendations for future research in this area. One is a need for appropriate controls such as sham/placebo control or other relevant active controls for testing the efficacy or effectiveness of acupuncture for PTSD in the design of parallel RCT or comparative effectiveness research. The second is outcomes should be used by validated one as primary one is PTSD scale and the secondary one is depression or anxiety with safety reporting. The third is high methodological quality is strongly required, as adequate randomization with allocation concealment, blinding of participants and assessors, or sample size estimation for power of trial, with following guideline of CONSORT and STRICTA.

5. Conclusions {#sec5}
==============

The results of this systematic review and meta-analysis suggest that evidence of the effectiveness of acupuncture for PTSD is encouraging but not cogent, because only two RCTs were included in meta-analysis, and it is too small to verify the efficacy of acupuncture. For the future researches, sham-controlled RCTs \[[@B50]\] or comparative effectiveness researches \[[@B51]\] are required to test efficacy and effectiveness of acupuncture for PTSD. To prevent performance bias and detection bias, blinding of participants and outcome assessment should be kept in future trials, too.

The authors report no financial relationship or other relevant to the subject of this paper.

![Flow chart of the trial selection process. PTSD: posttraumatic stress disorder; RCT: randomized controlled trial; UCT: uncontrolled clinical trial; AT: acupuncture.](ECAM2013-615857.001){#fig1}

###### 

Summary of randomized controlled trials and prospective clinical trials of acupuncture for posttraumatic stress disorder.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  First author \[ref\]\          Population                                  Study design           Sample\              Intervention/control group\    Treatment\        Main outcomes                                     Intergroup difference                                           Comments
  (year)\                                                                                           size/*N*, analyzed   (regime)                       session                                                                                                                             
  country                                                                                                                                                                                                                                                                                   
  ------------------------------ ------------------------------------------- ---------------------- -------------------- ------------------------------ ----------------- ------------------------------------------------- --------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  RCT (*n* = 4)                                                                                                                                                                                                                                                                              

                                                                                                                                                                                                                                                                                            

  Hollifield \[[@B18]\]\         28 out of 84 identified childhood abuse/\   3 arm parallel, open   84/73                \(A\) AT + AAT (*n* = 29)/\    24 sessions       \(1\) PTSD scale (PSS-SR)\                        \(1\) A versus B: *P* = 0.36, MD, −0.26 \[−0.83, 0.30\]\        The AT group had significantly better improvements in PTSD symptoms than the WLC group. But, there was no statistically significant difference between the AT group and the CBT group.
  (2007)\                        Others, unknown trauma                                                                  (B) CBT (*n* = 28)\                              (2) Depression (HSCL-25)\                           A versus C: *P* = 0.001, MD, −0.98 \[−1.58, −0.38\]\          
  U.S.A.                                                                                                                 (C) WLC (*n* = 27)\                              (3) Anxiety (HSCL-25)\                              B versus C: *P* = 0.004, MD, −0.85 \[−1.44, −0.27\]\          
                                                                                                                                                                          (4) Impairment (SDI)                              (2) A versus B: *P* = 0.92 MD, 0.03 \[−0.53, 0.59\]\            
                                                                                                                                                                                                                              A versus C: *P* = 0.02, MD, −0.68 \[−1.27, −0.10\]\           
                                                                                                                                                                                                                              B versus C: *P* = 0.008, MD, −0.80 \[−1.38, −0.21\]\          
                                                                                                                                                                                                                            (3) A versus B: *P* = 0.39, MD, −0.25 \[−0.81, 0.31\]\          
                                                                                                                                                                                                                              A versus C: *P* = 0.003, MD, −0.91 \[−1.51, −0.32\]\          
                                                                                                                                                                                                                              B versus C: *P* = 0.008, MD, −0.79 \[−1.37, −0.21\]\          
                                                                                                                                                                                                                            (4) A versus B: *P* = 0.98, MD, −0.01 \[−0.57, 0.55\]\          
                                                                                                                                                                                                                               A versus C: *P* = 0.03, MD, −0.64 \[−1.22, −0.06\]\          
                                                                                                                                                                                                                              B versus C: *P* = 0.03, MD, −0.64 \[−1.22, −0.07\]            

  Zhang \[[@B30]\] (2010)China   Earthquake                                  4 arm parallel, open   276/256              \(A\) EA (*n* = 69)\           36 sessions       \(1\) PTSD scale (CAPS)\                          \(1\) A versus D: *P* = 0.43, MD, −0.13 \[−0.47, 0.20\]\        The therapeutic effect of EA was not better than that of oral SSRI.
                                                                                                                         (B) EA + moxa (*n* = 69)\                        (2) Depression (HAMD)\                              B versus D: *P* = 0.88, MD, −0.03 \[−0.36, 0.31\]\            
                                                                                                                         (C) EA + AAT (*n* = 69)/\                        (3) Anxiety (HAMA)                                  C versus D: *P* = 0.55, MD, −0.10 \[−0.44, 0.23\]\            
                                                                                                                         (D) Oral SSRI (*n* = 69)                                                                           (2) A versus D: *P* = 0.14, MD, −0.25 \[−0.59, 0.08\]\          
                                                                                                                                                                                                                              B versus D: *P* = 0.34, MD, −0.16 \[−0.50, 0.17\]\            
                                                                                                                                                                                                                              C versus D: *P* = 0.23, MD, −0.21 \[−0.54, 0.13\]\            
                                                                                                                                                                                                                            (3) A versus D: *P* = 0.34, MD, −0.16 \[−0.50, 0.17\]\          
                                                                                                                                                                                                                              B versus D: *P* = 0.64, MD, −0.08 \[−0.41, 0.25\]\            
                                                                                                                                                                                                                              C versus D: *P* = 0.54, MD, 0.11 \[−0.23, 0.44\]              

  Zhang \[[@B36]\](2010)\        Earthquake                                  2 arm\                 92/81                \(A\) EA + moxa (*n* = 46)/\   36 sessions       \(1\) PTSD scale (CAPS)\                          \(1\) A versus B: *P* \< 0.00001, MD, −1.77 \[−2.26, −1.29\]\   EA plus moxa was more effective than oral SSRI therapy.\
  China                                                                      parallel\                                   (B) Oral SSRI (*n* = 46)                         (2) Depression (HAMD)\                            (2) A versus B: *P* \< 0.00001, MD, −1.96 \[−2.46, −1.46\]\     
                                                                             open                                                                                         (3) Anxiety (HAMA)                                (3) A versus B: *P* \< 0.00001, MD, −1.53 \[−2.00, −1.07\]      

  Zhang \[[@B37]\]\              Earthquake                                  2 arm\                 91/90                \(A\) Acupoint Stimulation\    3\~4 sessions\*   \(1\) PTSD scale (IES-R)\                         \(1\) A versus B: *P* \< 0.00001, MD, −1.56 \[−2.08, −1.04\]\   The acupoint stimulation plus CBT showed better efficacy than CBT therapy alone.\
  (2011)\                                                                    parallel\                                   + CBT (*n* = 67)/\                               (2) PTSD scale (self compiled questionnaire)      (2) A versus B: *P* = 0.01, MD, −0.59 \[−1.07, −0.12\]          
  China                                                                      open                                        (B) CBT (*n* = 24)                                                                                                                                                 

                                                                                                                                                                                                                                                                                            

  UCT (*n* = 2)                                                                                                                                                                                                                                                                              

                                                                                                                                                                                                                                                                                            

  Wang \[[@B38]\]\               Earthquake                                  UCT                    69                   EA + AAT + moxa                36 sessions       \(1\) The number of cured/improved/non-improved   Not applicable                                                  Treatment was effective in 65 out of 69 (94.2%).
  (2009)\                                                                                                                                                                                                                                                                                   
  China                                                                                                                                                                                                                                                                                     

  Yuan \[[@B39]\]\               Earthquake                                  UCT                    34                   AT                             20 sessions       \(1\) The number of cured/improved/non-improved   Not applicable                                                  AT was effective in 31 out of 34 (91.2%).
  (2009)\                                                                                                                                                                                                                                                                                   
  China                                                                                                                                                                                                                                                                                     
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: RCT: randomized controlled trial; UCT: uncontrolled clinical trial; AT: classical acupuncture; EA: electro-acupuncture; moxa, moxibustion; AAT: auricular acupuncture; CBT: cognitive behavioral therapy; WLC: waitlist control; SSRI: selective serotonin reuptake inhibitors; PSS-SR: posttraumatic symptom scale-self report; HSCL-25: self-rated Hopkins symptom checklist-25; SDI: Sheehan Disability Inventory; MD: mean difference; CAPS: clinician-administered PTSD scale; HAMD: Hamilton depression rating scale; HAMA: Hamilton anxiety rating scale; IES-R: Chinese version of the incident effect scale revised; \*treated a time every other day for 1 week.

###### 

Cochrane risk of bias of included randomized controlled trials.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------
  First author \[ref\]\                   Hollifield \[[@B18]\]\         Zhang \[[@B30]\] (2010)                            Zhang \[[@B36]\](2010)   Zhang \[[@B37]\]\
  (Year)                                  (2007)                                                                                                     (2011)
  --------------------------------------- ------------------------------ -------------------------------------------------- ------------------------ -------------------
  \(1\) Random sequence generation\       L\                             L\                                                 U                        U
  (selection bias)                        (computerized randomization)   (computerized randomization)                                                

  \(2\) Allocation concealment\           L\                             L\                                                 U                        U
  (selection bias)                        (central allocation)           (sequentially numbered, opaque sealed envelopes)                            

  \(3\) Blinding of participants\         H                              H                                                  H                        H
  (performance bias)                                                                                                                                 

  \(4\) Blinding of outcome assessment\   L\                             L\                                                 U                        U
  (detection bias)                        (mentioned)                    (mentioned)                                                                 

  \(5\) Incomplete outcome data\          L\                             U                                                  U                        U
  (attrition bias)                        (mentioned)                                                                                                

  \(6\) Selective reporting\              U                              U                                                  U                        U
  (reporting bias)                                                                                                                                   

  \(7\) Other sources of bias\            U                              U                                                  U                        U
  (other bias)                                                                                                                                       
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------

L: low risk of bias; H: high risk of bias; U: unclear.

###### 

Reporting quality of 4 included RCTs based on revised STRICTA.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Checklist item                              Hollifield et al. \[[@B18]\]\                                                                               Zhang et al. \[[@B30]\](2010)                                                       Zhang et al. \[[@B36]\](2010)                                   Zhang et al. \[[@B37]\](2011)
                                              (2007)                                                                                                                                                                                                                                                          
  ------------------------------------------- ----------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------- --------------------------------------------------------------- -----------------------------------------------------
  \(1\) Acupuncture rationale                                                                                                                                                                                                                                                                                  

   (1a) Style of\                             TCM                                                                                                         TCM                                                                                 TCM                                                             n.r.
   acupuncture                                                                                                                                                                                                                                                                                                

    (1b) Reasoning for\                       A paper by Napadow et al., 2005 \[[@B52]\]                                                                  A paper by Hollifield et al., 2007 \[[@B18]\]                                       A paper by Hollifield et al., 2007 \[[@B18]\]                   n.r.
   treatment provided                                                                                                                                                                                                                                                                                         

    (1c) Extent to which\                     2 types of AT\                                                                                              Fixed interventions\                                                                Fixed interventions\                                            Fixed intervention
   treatment was varied                       (1) AT: 25 fixed needles plus up to 3 flexible needles within 15 points\                                    (A) EA only\                                                                        EA + moxa                                                       
                                              (2) AAT: ≥6 vaccaria seeds                                                                                  (B) EA + moxa\                                                                                                                                      
                                                                                                                                                          (C) EA + AAT                                                                                                                                        

                                                                                                                                                                                                                                                                                                              

  \(2\) Details of needling                                                                                                                                                                                                                                                                                    

    (2a) Number of needle\                    \(1\) AT: 25 plus up to 3 needles\                                                                          \(1\) EA: 8 needles\                                                                EA: 8 needles                                                   unclear.
   insertions\                                (2) AAT: ≥6 vaccaria seeds                                                                                  (2) AAT: 6 vaccaria seeds                                                                                                                           
   per subject per session                                                                                                                                                                                                                                                                                    

    (2b) Names of points\                     \(1\) AT: bilateral at LR3, PC6, HT7, ST36, SP6, GB20, BL14, 15, 18, 20, 21 and 23/unilateral at Yintang\   \(1\) EA: bilateral at GB20/unilateral at GV24, EX-HN1, GV20\                       \(1\) EA: bilateral at GB20/unilateral at GV24, EX-HN1, GV20\   Unilateral at left PC8
   used                                       (2) AAT: unilateral at Shenmen, Sympathetic, Liver, Kidney, Lung points                                     (2) AAT: unilateral at Subcortex, Shenmen, Sympathetic, Heart, Liver, Kidney\       (2) moxa: bilateral at BL23, BL52/unilateral at GV4             
                                                                                                                                                          (3) moxa: bilateral at BL23, BL52/unilateral at GV4                                                                                                 

    (2c) Depth of insertion                   \(1\) AT: 1/4 to 1/2 inch\                                                                                  \(1\) EA: 0.5 to 1.2 cun\                                                           EA: 0.5 to 1.2 cun                                              n.r.
                                              (2) AAT: not inserted                                                                                       (2) AAT: not inserted                                                                                                                               

    (2d) Responses sought                     \(1\) AT: n.r.\                                                                                             \(1\) EA: de-qi\                                                                    EA: de-qi                                                       n.r.
                                              (2) AAT: not applicable                                                                                     (2) AAT: not applicable.                                                                                                                            

    (2e) Needle stimulation                   \(1\) AT: manipulation\                                                                                     \(1\) EA: electrical stimulation, 100 Hz\                                           EA: electrical stimulation,\                                    A Japanese stimulator with 50 Hz was used
                                              (2) AAT: self-massage on the seeds for 15 min/d                                                             (2) AAT: 1-2 min pressure                                                           5\~8.3 Hz                                                       

    (2f) Needle retention\                    \(1\) AT: 25--40 min\                                                                                       \(A\) 30 min\                                                                       30 min                                                          Unclear, but the left PC8 was stimulated for 30 min
   time                                       (2) AAT: unclear                                                                                            (B) 30 min\                                                                                                                                         
                                                                                                                                                          (C) 30 min                                                                                                                                          

    (2g) Needle type                          \(1\) AT: Viva needles, 34 g\                                                                               \(1\) EA: 0.30 mm × 40 mm\                                                          n.r.                                                            n.r.
                                              (2) AAT: vaccaria seeds                                                                                     (2) AAT: vaccaria seeds\                                                                                                                            

                                                                                                                                                                                                                                                                                                              

  \(3\) Treatment regimen                                                                                                                                                                                                                                                                                      

    (3a) Number of\                           24 sessions                                                                                                 36 sessions                                                                         \(1\) EA: 18 sessions\                                          3\~4 sessions\*
   treatment sessions                                                                                                                                                                                                                         (2) moxa: 36 sessions                                           

    (3b) Frequency and\                       Twice a week, 1 hour per session, 12 weeks                                                                  Three times a week, 12 weeks                                                        \(1\) EA: three times a week, 6 weeks\                          A time every other day for 1 week
   duration\                                                                                                                                                                                                                                  (2) moxa: three times a week, 12 weeks                          
   of treatment sessions                                                                                                                                                                                                                                                                                      

                                                                                                                                                                                                                                                                                                              

  \(4\) Other components\                                                                                                                                                                                                                                                                                      
  of treatment                                                                                                                                                                                                                                                                                                

    (4a) Details of other\                    Patients were taught how to use vaccaria seeds for symptom management                                       \(3\) moxa: 30 g and 20 min/session, wooden moxibustion box 20 mm × 15 mm × 12 mm   \(2\) moxa: 20 min/session                                      CBT
   interventions\                                                                                                                                                                                                                                                                                             
   administered\                                                                                                                                                                                                                                                                                              
   to the acupuncture\                                                                                                                                                                                                                                                                                        
   group                                                                                                                                                                                                                                                                                                      

    (4b) Setting and context\                 n.r.                                                                                                        n.r.                                                                                n.r.                                                            n.r.
   of treatment                                                                                                                                                                                                                                                                                               

                                                                                                                                                                                                                                                                                                              

  \(5\) Practitioner background                                                                                                                                                                                                                                                                                

    (5) Description of\                       Doctor of Oriental Medicine in New Mexico with 4 years postgraduate TCM clinical experience                 n.r.                                                                                n.r.                                                            n.r.
   participating\                                                                                                                                                                                                                                                                                             
   Acupuncturists                                                                                                                                                                                                                                                                                             

                                                                                                                                                                                                                                                                                                              

  \(6\) Control or comparator interventions                                                                                                                                                                                                                                                                    

    (6a) Rationale for the\                   \(B\) A review by Bisson and Andrew, 2005 \[[@B53]\] (C) not applicable                                     Approval of FDA                                                                     n.r.                                                            n.r.
   control\                                                                                                                                                                                                                                                                                                   
   or comparator                                                                                                                                                                                                                                                                                              

    (6b) Precise description\                 \(B\) CBT\                                                                                                  \(D\) Oral SSRI (Paroxetine 20 mg, once/day, 12 weeks)\                             Oral SSRI (Paroxetine 20 mg, once/day, 12 weeks)                \(B\) CBT
   of the control or\                         (C) WLC                                                                                                                                                                                                                                                         
   comparator                                                                                                                                                                                                                                                                                                 
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: RCT: randomized controlled trial; TCM: traditional Chinese medicine; n.r: not reported; AT: classical acupuncture; EA: electro-acupuncture; moxa, moxibustion; AAT: auricular acupuncture; CBT: cognitive behavioral therapy; WLC: waitlist control; SSRI: selective serotonin reuptake inhibitors.

\*treated a time every other day for 1 week.

###### 

Meta-analysis of acupuncture for posttraumatic stress disorder. PTSD: posttraumatic stress disorder; CAPS, clinician-administered PTSD scale; HAMD, Hamilton depression rating scale; HAMA, Hamilton anxiety rating scale; EA, electro-acupuncture; moxa, moxibustion; SSRI, selective serotonin reuptake inhibitors;

###### 

\(a\) PTSD scale (CAPS).

  --
  --

###### 

\(b\) Depression (HAMD).

  --
  --

###### 

\(c\) Anxiety (HAMA).

  --
  --

[^1]: Academic Editor: Hans-Christian Deter
